Delivery Order SPE2DB20D2104-SPE2DB24FT58Q
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,902.60 Firm Fixed Price Delivery Order is for the pharmaceutical product Ozempic 0.25-0.5 mg/dose pen 3 mL. The award has an ultimate completion date of November 9, 2023. This contract does not have a set-aside designation, indicating it was competitively awarded. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC), valued at $7,166.18. The contract is for the delivery of the pharmaceutical product Ozempic 0.25-0.5 mg/dose pen 3 mL to support federal healthcare programs. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 IDC with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,354.05 delivery order is for the pharmaceutical product Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, with a completion date of August 15, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of Ozempic 0.25-0.5 mg/dose pens. The $23,254.67 firm-fixed-price delivery order has a completion date of February 22, 2024 and is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,575.53 firm fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens, a medication used for diabetes management. The contract has an ultimate completion date of May 7, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,031.86 fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $4,670.30 firm fixed-price delivery order is for the pharmaceutical product Ozempic (0.25-0.5 mg/dose pen, 3 mL), with a completion date of May 3, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $9,297.54 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) for the pharmaceutical product Ozempic 0.25-0.5 mg/dose pen with a 3 mL capacity. The contract has an ultimate completion date of April 12, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, including the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Ozempic 0.25-0.5 mg/dose pens. The $3,697.45 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) on May 19, 2023, with a completion date of May 22, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,624.74 firm-fixed-price delivery order is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml medication. The award has an ultimate completion date of March 11, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FT58QDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,805.26 delivery order is for the pharmaceutical product Ozempic 0.25-0.5 mg/dose pen 3 mL. The contract has an ultimate completion date of April 12, 2024 and is a firm fixed-price delivery order. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This award is not designated with a set-aside. Amerisourcebergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 4/11/24 |